262 related articles for article (PubMed ID: 20814969)
1. Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone.
Thompson WR; Modla S; Grindel BJ; Czymmek KJ; Kirn-Safran CB; Wang L; Duncan RL; Farach-Carson MC
J Bone Miner Res; 2011 Mar; 26(3):618-29. PubMed ID: 20814969
[TBL] [Abstract][Full Text] [Related]
2. Single molecule force measurements of perlecan/HSPG2: A key component of the osteocyte pericellular matrix.
Wijeratne SS; Martinez JR; Grindel BJ; Frey EW; Li J; Wang L; Farach-Carson MC; Kiang CH
Matrix Biol; 2016 Mar; 50():27-38. PubMed ID: 26546708
[TBL] [Abstract][Full Text] [Related]
3. Perlecan-containing pericellular matrix regulates solute transport and mechanosensing within the osteocyte lacunar-canalicular system.
Wang B; Lai X; Price C; Thompson WR; Li W; Quabili TR; Tseng WJ; Liu XS; Zhang H; Pan J; Kirn-Safran CB; Farach-Carson MC; Wang L
J Bone Miner Res; 2014 Apr; 29(4):878-91. PubMed ID: 24115222
[TBL] [Abstract][Full Text] [Related]
4. Solute Transport in the Bone Lacunar-Canalicular System (LCS).
Wang L
Curr Osteoporos Rep; 2018 Feb; 16(1):32-41. PubMed ID: 29349685
[TBL] [Abstract][Full Text] [Related]
5. Trabecular Bone Deficit and Enhanced Anabolic Response to Re-Ambulation after Disuse in Perlecan-Deficient Skeleton.
Parajuli A; Pei S; Zhao H; Martinez JR; Lu XL; Liu XS; Farach-Carson MC; Kirn-Safran CB; Wang L
Biomolecules; 2020 Jan; 10(2):. PubMed ID: 32013135
[TBL] [Abstract][Full Text] [Related]
6. Perlecan-deficient mutation impairs corneal epithelial structure.
Inomata T; Ebihara N; Funaki T; Matsuda A; Watanabe Y; Ning L; Xu Z; Murakami A; Arikawa-Hirasawa E
Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1277-84. PubMed ID: 22266517
[TBL] [Abstract][Full Text] [Related]
7. Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis.
Shu CC; Jackson MT; Smith MM; Smith SM; Penm S; Lord MS; Whitelock JM; Little CB; Melrose J
Arthritis Rheumatol; 2016 Apr; 68(4):868-79. PubMed ID: 26636652
[TBL] [Abstract][Full Text] [Related]
8. The heparan sulphate deficient Hspg2 exon 3 null mouse displays reduced deposition of TGF-β1 in skin compared to C57BL/6 wild type mice.
Shu C; Smith SM; Melrose J
J Mol Histol; 2016 Jun; 47(3):365-74. PubMed ID: 27098652
[TBL] [Abstract][Full Text] [Related]
9. Perlecan Knockdown Significantly Alters Extracellular Matrix Composition and Organization During Cartilage Development.
Ocken AR; Ku MM; Kinzer-Ursem TL; Calve S
Mol Cell Proteomics; 2020 Jul; 19(7):1220-1235. PubMed ID: 32381549
[TBL] [Abstract][Full Text] [Related]
10. Deficiency in perlecan/HSPG2 during bone development enhances osteogenesis and decreases quality of adult bone in mice.
Lowe DA; Lepori-Bui N; Fomin PV; Sloofman LG; Zhou X; Farach-Carson MC; Wang L; Kirn-Safran CB
Calcif Tissue Int; 2014 Jul; 95(1):29-38. PubMed ID: 24798737
[TBL] [Abstract][Full Text] [Related]
11. Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation.
Ishijima M; Suzuki N; Hozumi K; Matsunobu T; Kosaki K; Kaneko H; Hassell JR; Arikawa-Hirasawa E; Yamada Y
Matrix Biol; 2012 May; 31(4):234-45. PubMed ID: 22421594
[TBL] [Abstract][Full Text] [Related]
12. Disrupted osteocyte connectivity and pericellular fluid flow in bone with aging and defective TGF-β signaling.
Schurman CA; Verbruggen SW; Alliston T
Proc Natl Acad Sci U S A; 2021 Jun; 118(25):. PubMed ID: 34161267
[TBL] [Abstract][Full Text] [Related]
13. Perlecan deficiency causes muscle hypertrophy, a decrease in myostatin expression, and changes in muscle fiber composition.
Xu Z; Ichikawa N; Kosaki K; Yamada Y; Sasaki T; Sakai LY; Kurosawa H; Hattori N; Arikawa-Hirasawa E
Matrix Biol; 2010 Jul; 29(6):461-70. PubMed ID: 20541011
[TBL] [Abstract][Full Text] [Related]
14. Perlecan/Hspg2 deficiency impairs bone's calcium signaling and associated transcriptome in response to mechanical loading.
Pei S; Parthasarathy S; Parajuli A; Martinez J; Lv M; Jiang S; Wu D; Wei S; Lu XL; Farach-Carson MC; Kirn-Safran CB; Wang L
Bone; 2020 Feb; 131():115078. PubMed ID: 31715337
[TBL] [Abstract][Full Text] [Related]
15. Perlecan, a modular instructive proteoglycan with diverse functional properties.
Melrose J
Int J Biochem Cell Biol; 2020 Nov; 128():105849. PubMed ID: 32947020
[TBL] [Abstract][Full Text] [Related]
16. Perlecan heparan sulfate deficiency impairs pulmonary vascular development and attenuates hypoxic pulmonary hypertension.
Chang YT; Tseng CN; Tannenberg P; Eriksson L; Yuan K; de Jesus Perez VA; Lundberg J; Lengquist M; Botusan IR; Catrina SB; Tran PK; Hedin U; Tran-Lundmark K
Cardiovasc Res; 2015 Jul; 107(1):20-31. PubMed ID: 25952902
[TBL] [Abstract][Full Text] [Related]
17. Perlecan is required for the chondrogenic differentiation of synovial mesenchymal cells through regulation of Sox9 gene expression.
Sadatsuki R; Kaneko H; Kinoshita M; Futami I; Nonaka R; Culley KL; Otero M; Hada S; Goldring MB; Yamada Y; Kaneko K; Arikawa-Hirasawa E; Ishijima M
J Orthop Res; 2017 Apr; 35(4):837-846. PubMed ID: 27238423
[TBL] [Abstract][Full Text] [Related]
18. Perlecan is essential for cartilage and cephalic development.
Arikawa-Hirasawa E; Watanabe H; Takami H; Hassell JR; Yamada Y
Nat Genet; 1999 Nov; 23(3):354-8. PubMed ID: 10545953
[TBL] [Abstract][Full Text] [Related]
19. Type XI collagen-perlecan-HS interactions stabilise the pericellular matrix of annulus fibrosus cells and chondrocytes providing matrix stabilisation and homeostasis.
Smith SM; Melrose J
J Mol Histol; 2019 Jun; 50(3):285-294. PubMed ID: 30993430
[TBL] [Abstract][Full Text] [Related]
20. Elevated hypertrophy, growth plate maturation, glycosaminoglycan deposition, and exostosis formation in the
Shu CC; Smith SM; Little CB; Melrose J
Biochem J; 2019 Jan; 476(2):225-243. PubMed ID: 30563944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
